AKT1 and breast cancer: We conclude that AKT kinase is an immediate upstream regulator of SOX2 turnover in BC, and that the disappearance of SOX2 protein in AKT-inhibited cells is not primarily explained by altered de novo protein synthesis (Figure 3E).